The nurse is caring for a pregnant client at 7-weeks gestation with type II diabetes. The client's glycosylated hemoglobin (HbA1C) level is 8.9 What is the priority fetal concern at this time?
Explanation & Rationale
Choice A rationale Macrosomia, or excessive birth weight, is a common complication of maternal diabetes, but it is typically a concern in the second and third trimesters. It occurs due to fetal hyperinsulinemia in response to high maternal glucose levels. At 7 weeks gestation, the fetus is in the embryonic stage, and the primary physiological process is organogenesis rather than rapid weight gain or fat deposition. Therefore, while macrosomia is a significant risk later in pregnancy, it is not the priority fetal concern during the first trimester. Choice B rationale At 7 weeks gestation, the embryo is undergoing organogenesis, the critical period when major organs are formed. A glycosylated hemoglobin (HbA1C) of 8.9 percent (normal range typically below 5.7 percent) indicates poor glycemic control in the weeks leading up to and during early pregnancy. High glucose levels are teratogenic during this window, significantly increasing the risk of major congenital anomalies, particularly cardiac defects and sacral agenesis. Establishing euglycemia early is vital to reduce the risk of structural malformations during these formative weeks. Choice C rationale Cephalopelvic disproportion (CPD) occurs when the fetal head is too large to pass through the maternal pelvis, often as a result of fetal macrosomia. Like macrosomia, this is a concern at the end of pregnancy and during the labor process. At 7 weeks gestation, the embryo is only a few millimeters long, and the physical dimensions relative to the birth canal are irrelevant. The focus during the first trimester must be on the viability and structural integrity of the developing embryo rather than delivery complications. Choice D rationale Hyperbilirubinemia is a neonatal complication that occurs after birth. It is often seen in infants of diabetic mothers due to polycythemia and the subsequent breakdown of excess red blood cells. While maternal hyperglycemia during pregnancy contributes to this risk, it is not a concern that can manifest or be addressed at 7 weeks gestation. The priority at this early stage is the prevention of developmental errors that could lead to miscarriage or permanent structural birth defects.